Detection, Identification, and Distribution of Fungi in Bronchoalveolar Lavage Specimens by Use of Multilocus PCR Coupled with Electrospray Ionization/Mass Spectrometry

ABSTRACT As pulmonary fungal infections continue to increase due to an increasing number of immunocompromised patients, rapid detection and accurate identification of these fungal pathogens are critical. A broad fungal assay was developed by incorporating broad-range multilocus PCR amplification and electrospray ionization/mass spectrometry (PCR/ESI-MS) to detect and identify fungal organisms directly from clinical specimens. The aims of this study were to evaluate the performance of PCR/ESI-MS for detection, identification, and determination of the distribution of fungal organisms in bronchoalveolar lavage (BAL) fluid specimens. The BAL fluid specimens submitted for fungal culture at Vanderbilt University Medical Center between May 2005 and October 2011 were included. Cultures and identification were done using standard procedures. In addition, DNA was extracted from BAL fluid specimens, and fungal DNA amplification/identification were performed by PCR/ESI-MS. The results were compared with those of the standard cultures. A total of 691 nonduplicated BAL fluid specimens with sufficient leftover volume for molecular testing were evaluated using PCR/ESI-MS. Among them, 134 specimens (19.4%) were positive for fungi by both culture and PCR/ESI-MS testing. Of the dual-positive specimens, 125 (93.3%) were positive for Candida and Aspergillus species, with concordances between culture and PCR/ESI-MS results being 84 (67.2%) at the species level and 109 (87.2%) at the genus level. In addition, 243 (35.2%) and 30 (4.3%) specimens were positive only by PCR/ESI-MS or by culture, respectively (odds ratio [OR] = 11.95, 95% confidence interval [CI] = 7.90 to 18.17, P = 0.0000). Codetection of fungal organisms was noted in 23 (3.3%) specimens by PCR/ESI-MS, which was significantly higher than the 4 (0.6%) in which they were noted by culture (OR = 5.91, 95% CI = 1.93 to 20.27, P = 0.0002). Among 53 specimens in which cultures failed because of bacterial overgrowth, at least one fungus was identified in 26 specimens (47.3%) by PCR/ESI-MS. PCR/ESI-MS provides an advanced tool for rapid and sensitive detection, identification, and determination of the distribution of fungal organisms directly from BAL fluid specimens. Moreover, it detected fungal organisms in specimens in which cultures failed because of bacterial overgrowth. The clinical relevance of the significantly higher detection rate of fungal organisms by PCR/ESI-MS merits further investigation.

[1]  C. Ki,et al.  Identification of Clinical Mold Isolates by Sequence Analysis of the Internal Transcribed Spacer Region, Ribosomal Large-Subunit D1/D2, and β-Tubulin , 2012, Annals of laboratory medicine.

[2]  J. Shin,et al.  Evaluation of DNA Extraction Methods and Their Clinical Application for Direct Detection of Causative Bacteria in Continuous Ambulatory Peritoneal Dialysis Culture Fluids from Patients with Peritonitis by Using Broad-Range PCR , 2012, Annals of laboratory medicine.

[3]  J. Schrenzel,et al.  Comparative Analysis of PCR–Electrospray Ionization/Mass Spectrometry (MS) and MALDI-TOF/MS for the Identification of Bacteria and Yeast from Positive Blood Culture Bottles , 2011, Clinical chemistry.

[4]  W. Meyer,et al.  Development and Validation of a Multiplex PCR for Detection of Scedosporium spp. in Respiratory Tract Specimens from Patients with Cystic Fibrosis , 2011, Journal of Clinical Microbiology.

[5]  John W. Wilson,et al.  Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity. , 2011, Diagnostic microbiology and infectious disease.

[6]  D. Ecker,et al.  Rapid identification viruses from nasal pharyngeal aspirates in acute viral respiratory infections by RT-PCR and electrospray ionization mass spectrometry , 2011, Journal of Virological Methods.

[7]  J. Schrenzel,et al.  Use of PCR Coupled with Electrospray Ionization Mass Spectrometry for Rapid Identification of Bacterial and Yeast Bloodstream Pathogens from Blood Culture Bottles , 2010, Journal of Clinical Microbiology.

[8]  T. Peláez,et al.  Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  Susan E. Sefers,et al.  Detection and Identification of Ehrlichia Species in Blood by Use of PCR and Electrospray Ionization Mass Spectrometry , 2009, Journal of Clinical Microbiology.

[10]  D. Ecker,et al.  Rapid and High-Throughput pan-Orthopoxvirus Detection and Identification using PCR and Mass Spectrometry , 2009, PloS one.

[11]  A. Hoeft,et al.  Utility of a Commercially Available Multiplex Real-Time PCR Assay To Detect Bacterial and Fungal Pathogens in Febrile Neutropenia , 2009, Journal of Clinical Microbiology.

[12]  R. Sampath,et al.  Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates. , 2009, Diagnostic microbiology and infectious disease.

[13]  David J. Ecker,et al.  Ibis T5000: a universal biosensor approach for microbiology , 2008, Nature Reviews Microbiology.

[14]  K. Kleesiek,et al.  Evaluation of Novel Broad-Range Real-Time PCR Assay for Rapid Detection of Human Pathogenic Fungi in Various Clinical Specimens , 2008, Journal of Clinical Microbiology.

[15]  C. Rubin,et al.  Multiplex Real-Time PCR Targeting the RNase P RNA Gene for Detection and Identification of Candida Species in Blood , 2007, Journal of Clinical Microbiology.

[16]  A. Wilmer,et al.  Invasive aspergillosis in critically ill patients without malignancy. , 2004, American journal of respiratory and critical care medicine.

[17]  M. Aoun,et al.  Rapid Detection of Candida albicans in Clinical Blood Samples by Using a TaqMan-Based PCR Assay , 2003, Journal of Clinical Microbiology.

[18]  R. Hehlmann,et al.  Development of a LightCycler PCR Assay for Detection and Quantification of Aspergillus fumigatus DNA in Clinical Samples from Neutropenic Patients , 2003, Journal of Clinical Microbiology.

[19]  T. G. Mitchell,et al.  Rapid Identification of Pathogenic Fungi Directly from Cultures by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.

[20]  D. Soll,et al.  Identification of Candida dubliniensis Based on Temperature and Utilization of Xylose and α-Methyl-d-Glucoside as Determined with the API 20C AUX and Vitek YBC Systems , 1999, Journal of Clinical Microbiology.

[21]  N. Ampel,et al.  American Thoracic Society Documents an Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients Contents Introduction Methods Antifungal Agents: General Considerations Polyenes Triazoles Echinocandins Treatment of Fungal Infections Hi , 2022 .

[22]  A. Wilmer,et al.  Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. , 2008, American journal of respiratory and critical care medicine.

[23]  D. Stevens Diagnosis of fungal infections: current status. , 2002, The Journal of antimicrobial chemotherapy.

[24]  A. Fraise Biocide abuse and antimicrobial resistance--a cause for concern? , 2002, The Journal of antimicrobial chemotherapy.